ES2062098T3 - Derivados de bencimidazol farmacologicamente activos. - Google Patents

Derivados de bencimidazol farmacologicamente activos.

Info

Publication number
ES2062098T3
ES2062098T3 ES89830312T ES89830312T ES2062098T3 ES 2062098 T3 ES2062098 T3 ES 2062098T3 ES 89830312 T ES89830312 T ES 89830312T ES 89830312 T ES89830312 T ES 89830312T ES 2062098 T3 ES2062098 T3 ES 2062098T3
Authority
ES
Spain
Prior art keywords
pharmacologically active
elected
group
bencimidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89830312T
Other languages
English (en)
Spanish (es)
Inventor
Roberto Giani
Ettore Parini
Giancarlo Tonon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dompe Farmaceutici SpA
Original Assignee
Dompe Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Farmaceutici SpA filed Critical Dompe Farmaceutici SpA
Application granted granted Critical
Publication of ES2062098T3 publication Critical patent/ES2062098T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S165/00—Heat exchange
    • Y10S165/009—Heat exchange having a solid heat storage mass for absorbing heat from one fluid and releasing it to another, i.e. regenerator
    • Y10S165/013—Movable heat storage mass with enclosure
    • Y10S165/016—Rotary storage mass
    • Y10S165/02—Seal and seal-engaging surface are relatively movable
    • Y10S165/024—Circumferential seal

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES89830312T 1988-07-07 1989-07-06 Derivados de bencimidazol farmacologicamente activos. Expired - Lifetime ES2062098T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8821271A IT1226100B (it) 1988-07-07 1988-07-07 Derivati benzimidazolici farmacologicamente attivi.

Publications (1)

Publication Number Publication Date
ES2062098T3 true ES2062098T3 (es) 1994-12-16

Family

ID=11179331

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89830312T Expired - Lifetime ES2062098T3 (es) 1988-07-07 1989-07-06 Derivados de bencimidazol farmacologicamente activos.

Country Status (7)

Country Link
US (1) US4971980A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0350467B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0267272A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE99295T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE68911773T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2062098T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1226100B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.
EP0561973A1 (en) * 1990-12-14 1993-09-29 Merrell Dow Pharmaceuticals Inc. Antiallergic compounds
TW263504B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1991-10-03 1995-11-21 Pfizer
IT1264456B1 (it) * 1993-05-14 1996-09-23 Dompe Farmaceutici Spa Derivati del 2-(benzimidazol-2-il)-1,3-diaminopropano farmacologicamente attivi.
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
GB9600143D0 (en) 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
KR100494448B1 (ko) * 1996-06-04 2005-12-02 화브리까 에스파놀라 데 프로둑또스 뀌미꼬스 이 화르마세우띠꼬스 쏘시에떼 아노님 항히스타민활성을가지는신규한벤조이미다졸유도체
JP2001512453A (ja) 1997-02-13 2001-08-21 グラックス グループ リミテッド ベンゾイミダゾール誘導体
NZ501415A (en) 1997-06-10 2001-10-26 Glaxo Group Ltd Benzimidazole derivatives (optionally with saccharide substituents) useful for the treatment or prophylaxis of viral infections (particularly herpes, cytomegalovirus and Hepatitis B) or for the treatment or prophylaxis of restenosis
US6455506B1 (en) 1997-07-30 2002-09-24 Smithkline Beecham Corporation Lyxofuranosyl benzimidazoles as antiviral agents
TR200600172T2 (tr) * 1999-06-28 2007-10-22 Janssen Pharmaceutica N.V Solunum sistemi sinsitiyal virüsünün replikasyonunu inhibe edici maddeler.
WO2001000588A1 (fr) * 1999-06-28 2001-01-04 Fuji Photo Film Co., Ltd. Composes de benzimidazole et medicaments les contenant
DE60013607T2 (de) 1999-06-30 2005-09-29 Fuji Photo Film Co., Ltd., Minami-Ashigara Bemzimidazolverbindungen und medikamente die diese enthalten
WO2001004110A1 (fr) 1999-07-07 2001-01-18 Fuji Photo Film Co., Ltd. Composes de benzimidazole
US6349662B1 (en) * 2000-12-29 2002-02-26 Taco Metals, Inc. Rub rail
WO2007106192A2 (en) * 2005-12-19 2007-09-20 Genentech, Inc. Inhibitors of iap

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1023792A (en) * 1963-04-17 1966-03-23 Smith & Nephew Benzimidazole derivatives and processes for making them
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
US4462992A (en) * 1982-02-08 1984-07-31 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
JPS59199679A (ja) * 1983-04-27 1984-11-12 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
US4728741A (en) * 1985-01-08 1988-03-01 Smithkline Beckman Corporation 1-substituted-2-mercapto benzimidazole compounds and intermediates

Also Published As

Publication number Publication date
US4971980A (en) 1990-11-20
IT1226100B (it) 1990-12-10
ATE99295T1 (de) 1994-01-15
EP0350467B1 (en) 1993-12-29
EP0350467A1 (en) 1990-01-10
IT8821271A0 (it) 1988-07-07
JPH0267272A (ja) 1990-03-07
JPH0567624B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-09-27
DE68911773D1 (de) 1994-02-10
DE68911773T2 (de) 1994-07-07

Similar Documents

Publication Publication Date Title
ES2062098T3 (es) Derivados de bencimidazol farmacologicamente activos.
ES2063036T3 (es) Compuestos (aralquil-sustituido) heterociclicos.
ES2121896T3 (es) Derivados de acido hidroxamico como inhibidores de colagenasa.
UA26427A (uk) Похідhі ксаhтиhу у вигляді суміші ізомерів або іhдивідуальhих ізомерів, що мають властивість аhтагоhіста адеhозиhу
ES2134926T3 (es) Derivados vinileno-azaindolicos y su procedimiento de preparacion.
FI895689A0 (fi) Substituerade tiazoler och anvaendning av dessa som fungicider.
ES2179071T3 (es) Agentes vasodilatadores perifericos que comprenden como principio activo derivados de la piperidina 4-amino n-acilada.
ES2137628T3 (es) Derivados de estilbeno y composiciones farmaceuticas que los contienen.
ES2065133T3 (es) Derivados de piperazina.
ES2081302T3 (es) Aril- y heteroaril-piperazinil carboxamidas que tienen actividad sobre el sistema nervioso central.
FI930991A0 (fi) Polymerer som innehaoller diesterenheter
HUT59663A (en) Process for producing new d vitamine analogues and pharmaceutical compositions containing them as active components
ES2134764T3 (es) Inhibidores de hiv proteasa.
ES2248114T3 (es) Derivados de sulfonamida farmaceuticamente activos.
ES2156157T3 (es) Derivado de ciclopenteno heteroaromatico fusionado con una actividad antagonista de la endotelina.
ES2128557T3 (es) Derivados de poliamina como agentes radioprotectores.
ES2057959T3 (es) Derivados de tienopiridina y composiciones farmaceuticas que los contienen.
ES2060709T3 (es) Derivados de piridilo y pirimidilo.
ES2059625T3 (es) Un procedimiento para preparar un derivado de hidroxialquilcisteina.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
MX9300361A (es) Derivado de 4-aril-3-heteroarilureidoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES2153019T3 (es) Derivados de benzo-dioxano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2120406T3 (es) Derivados de triazol.
ES2119874T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 350467

Country of ref document: ES